Truace
Subscribe

Enhancing diagnostic precision for BI-RADS 4a breast nodules: A multimodal AI model integrating ultrasound radiomics, hemodynamic signatures, and clinical profiles

Background Breast Imaging Reporting and Data System (BI-RADS) 4a nodules represent a diagnostic dilemma, with a malignancy rate ranging from 2% to 10%. The majority of these nodules prove benign after biopsy, leading to unnecessary invasive procedures, patient anxiety, and healthcare costs. Current clinical practice lacks a reliable, noninvasive tool to accurately distinguish benign from malignant BI-RADS 4a lesions. Emerging evidence suggests that integrating multiparametric ultrasound data with clinical factor…

By the Truvace desk2 min read1 sourcePeer-reviewedTRV-2026-1239· cite & verify
Enhancing diagnostic precision for BI-RADS 4a breast nodules: A multimodal AI model integrating ultrasound radiomics, hemodynamic signatures, and clinical profiles
Hospital Universitari Doctor Peset, València 08 by 19Tarrestnom65. CC BY-SA 4.0 · https://creativecommons.org/licenses/by-sa/4.0

In brief

Researchers developed and validated a multimodal AI model to resolve the diagnostic ambiguity of BI-RADS 4a breast nodules, which have a 2% to 10% malignancy rate and often lead to benign biopsy results. Using data from 350 pathologically confirmed nodules across three hospitals, the LightGBM model combined ultrasound radiomics, hemodynamic features, and clinical profiles, achieving an AUC of 0.95 on a temporally independent test set of 90 nodules as of the October 2026 publication.

The result matters because BI-RADS 4a management currently lacks a reliable noninvasive tool, contributing to unnecessary invasive procedures, patient anxiety, and costs. A tool that maintains 100% sensitivity while improving specificity could support clinical decision-making and safely reduce biopsies, though real-world impact, generalizability beyond the three study hospitals, and prospective clinical utility remain to be confirmed.

Main points

  1. Prospective multicenter study enrolled 350 pathologically confirmed BI-RADS 4a nodules from 331 patients in one tertiary hospital and two secondary hospitals.
  2. Model was built with Light Gradient Boosting Machine after LASSO feature selection, using grayscale ultrasound radiomics, hemodynamic parameters, and clinical data.
  3. Training set n=260 with nested cross-validation and hyperparameter tuning; evaluation on temporally independent test set n=90.
  4. Test performance significantly superior to Logistic Regression, Support Vector Machine, and Random Forest baseline classifiers.

The gain

A LightGBM-based multimodal model integrating ultrasound radiomics, hemodynamic signatures and clinical data achieved high diagnostic accuracy on BI-RADS 4a nodules, supporting safer reduction of unnecessary biopsies.

The rundown

The study collected clinical data, grayscale ultrasound images, and hemodynamic parameters for each nodule and extracted radiomics features, then constructed a multimodal fusion model using LightGBM following LASSO regression for feature selection.

Interpretability was addressed with SHapley Additive exPlanations (SHAP), and the model was developed on 260 nodules and tested on 90 temporally independent nodules, reporting AUC 0.95 with 100% sensitivity and 86.1% specificity.

Sources

  1. Peer-reviewedJournal of Applied Clinical Medical Physics2026-10-01

The debate